Fujifilm Healthcare
Japanese imaging and healthcare-IT manufacturer with origins in X-ray film and photographic products. The medical imaging division grew through organic development and strategic acquisitions; the 2021 acquisition of Hitachi's Diagnostic Imaging business roughly doubled the imaging portfolio overnight, adding MRI, CT, and the Aloka / Arietta ultrasound lines to a roster previously focused on mammography, DR, ultrasound (Sonosite), and PACS.
Company history
- 1934 — Fujifilm founded in Japan as Fuji Photo Film.
- 2000s — photographic-film business contracts; strategic pivot to healthcare, specialty chemicals, and document solutions. Synapse PACS launched.
- 2006 — acquires Toyama Chemical (pharmaceuticals).
- 2012 — acquires SonoSite (point-of-care ultrasound), establishing leadership in handheld / portable POCUS.
- 2021 — acquires Hitachi's Diagnostic Imaging business for ~$1.6B; Hitachi's MRI, CT, and ultrasound product lines roll into Fujifilm Healthcare. Branded as Fujifilm Healthcare going forward.
Product line by modality
- Mammography — ASPIRE Cristalle (2D + tomo + biopsy), AMULET Innovality. Direct competitor to Hologic Selenia / 3Dimensions.
- Digital radiography — FDR series (DR rooms), FDR Go PLUS / FDR Cross (mobile DR), FDR Visionary Suite (premium fixed). DR detector technology — Fujifilm has its own DR detector R&D lineage.
- CR (computed radiography) — long history of CR readers (FCR series); now legacy but still installed globally in lower-tier sites.
- Ultrasound — SonoSite (point-of-care: SII, X-Porte, PX, Edge, M-Turbo, iViz handhelds), plus Hitachi-lineage Aloka / Arietta carts (general radiology, cardiac, vascular).
- MRI — Hitachi-lineage Echelon family (1.5T), Airis (open low-field), Oasis (1.2T open superconducting).
- CT — Hitachi-lineage Supria / Scenaria systems.
- Endoscopy — Fujifilm's traditional GI / bronchoscopy / ENT endoscope business; strong global share in GI endoscopy.
- PACS / enterprise imaging — Synapse (enterprise-grade PACS / VNA / RIS, top-tier global share; one of the few non-OEM-tied PACS platforms with installed base across all the Big Three's customers).
Distinctive technology
- ISS (Irradiation Side Sampling) detector architecture on FDR DR — reads through the same side as X-ray entry, claimed DQE benefits.
- Hexagonal pixel layout on Cristalle / AMULET tomo platforms — Fujifilm's mammography detector lineage.
- REiLI AI platform — vendor-agnostic radiology AI deployed on Synapse and Fujifilm imaging consoles.
- SonoSite ruggedization — POCUS hardware engineered for ED, ICU, military, and field-medicine environments.
Market position
- Point-of-care ultrasound: leader globally via SonoSite.
- Mammography: top-tier internationally; competitive with Hologic Selenia / 3Dimensions in markets outside the U.S. and growing U.S. share.
- Enterprise imaging / PACS: top-three globally via Synapse — sometimes the largest non-OEM-affiliated PACS vendor by site count.
- MRI / CT (post-Hitachi): meaningful presence, with strongest niche in open / low-field MRI (Oasis, Airis) and value-segment CT.
- Endoscopy: top-tier globally.
Refurb posture
- SonoSite POCUS is widely refurbished with strong probe-supply ecosystem.
- Hitachi-lineage MRI / CT / US carries a substantial installed base in markets where Hitachi was historically strong (Japan, Asia-Pacific, Latin America); refurb supply tracks that footprint.
- Mammography (ASPIRE / AMULET) has growing refurb activity as units age out of premium imaging centers.
- Synapse PACS is software / subscription-licensed, not refurbed in the conventional capital sense.